Treatment Outcome of Tuberculosis and Associated Factors among TB-HIV Co-Infected Patients at Public Hospitals of Harar Town, Eastern Ethiopia. A five-year retrospective study

Abstract Background The bidirectional relationship between the twin epidemics of Tuberculosis (TB) and Human Immunodeficiency Virus (HIV) causes major global health challenges in the twenty-first century. TB-HIV co-infected people are facing multifaceted problems like high lost to follow up rates, p...

Full description

Bibliographic Details
Main Authors: Assefa Tola, Kirubel Minsamo Mishore, Yohanes Ayele, Abraham Nigussie Mekuria, Nanati Legese
Format: Article
Language:English
Published: BMC 2019-12-01
Series:BMC Public Health
Subjects:
Online Access:https://doi.org/10.1186/s12889-019-7980-x
_version_ 1818850239901073408
author Assefa Tola
Kirubel Minsamo Mishore
Yohanes Ayele
Abraham Nigussie Mekuria
Nanati Legese
author_facet Assefa Tola
Kirubel Minsamo Mishore
Yohanes Ayele
Abraham Nigussie Mekuria
Nanati Legese
author_sort Assefa Tola
collection DOAJ
description Abstract Background The bidirectional relationship between the twin epidemics of Tuberculosis (TB) and Human Immunodeficiency Virus (HIV) causes major global health challenges in the twenty-first century. TB-HIV co-infected people are facing multifaceted problems like high lost to follow up rates, poor treatment adherence, high TB recurrence rate, and high mortality risk. Our objective was to assess the outcomes of TB treatment and associated factors among TB-HIV co-infected patients in Harar town, Eastern part of Ethiopia, 2018. Methods A retrospective study was conducted among systematically selected 349 TB/HIV co-infected patients who registered from 2012 to 2017 in two public hospitals in Harar town. The data were collected through document review by using a pre-tested structured data extraction checklist. The data were analyzed using SPSS Version 21. Bivariate and multivariate logistic regression were determined at 95% confidence intervals. Results Among the 349 TB/HIV co-infected patients included in the study, 30.1% were cured, 56.7% had completed their treatment, 7.7% died, 1.7% were lost to follow up, and 3.7% were treatment failure. Overall, 86.8% of the TB-HIV co-infected patients had successful TB treatment outcomes. The patients who were on re-treatment category (AOR = 2.91, 95% CI: 1.17–7.28), who had a history of opportunistic infection (AOR = 3.68, 95% CI: 1.62–8.33), and who did not take co-trimoxazole prophylaxis (AOR = 3.54, 95% CI: 1.59–7.89) had 2.91, 3.68, and 3.54 times higher odds of having unsuccessful TB treatment outcome than their counterparties, respectively. The chance of unsuccessful TB treatment outcome was 4.46 (95% CI: 1.24–16.02), 5.94 (95% CI: 1.87–18.85), and 3.01 (95% CI: 1.15–7.91) times higher among TB/HIV patients in stage 2, 3 and 4 than those in stage 1, respectively. Conclusions The overall rate of the success of the TB treatment among TB-HIV co-infected patients in this study was higher compared with many previous studies. TB/HIV patients with a history of previous TB treatment, smear-positive pulmonary TB, late HIV stage, history of opportunistic infection and not being on co-trimoxazole prophylaxis therapy were at a high risk of getting poor treatment outcomes.
first_indexed 2024-12-19T06:45:59Z
format Article
id doaj.art-0bc4134e2356420db2395b9359e58cf2
institution Directory Open Access Journal
issn 1471-2458
language English
last_indexed 2024-12-19T06:45:59Z
publishDate 2019-12-01
publisher BMC
record_format Article
series BMC Public Health
spelling doaj.art-0bc4134e2356420db2395b9359e58cf22022-12-21T20:31:53ZengBMCBMC Public Health1471-24582019-12-0119111210.1186/s12889-019-7980-xTreatment Outcome of Tuberculosis and Associated Factors among TB-HIV Co-Infected Patients at Public Hospitals of Harar Town, Eastern Ethiopia. A five-year retrospective studyAssefa Tola0Kirubel Minsamo Mishore1Yohanes Ayele2Abraham Nigussie Mekuria3Nanati Legese4Department of Epidemiology and Biostatistics, School of public health, College of Health and Medical Sciences, Haramaya UniversityDepartment of Clinical Pharmacy, School of Pharmacy, College of Health and Medical Sciences, Haramaya UniversityDepartment of Clinical Pharmacy, School of Pharmacy, College of Health and Medical Sciences, Haramaya UniversityDepartment of Pharmacology, School of Pharmacy, College of Health and Medical Sciences, Haramaya UniversityDepartment of pharmaceutics and social pharmacy, School of Pharmacy, College of Health and Medical Sciences, Haramaya UniversityAbstract Background The bidirectional relationship between the twin epidemics of Tuberculosis (TB) and Human Immunodeficiency Virus (HIV) causes major global health challenges in the twenty-first century. TB-HIV co-infected people are facing multifaceted problems like high lost to follow up rates, poor treatment adherence, high TB recurrence rate, and high mortality risk. Our objective was to assess the outcomes of TB treatment and associated factors among TB-HIV co-infected patients in Harar town, Eastern part of Ethiopia, 2018. Methods A retrospective study was conducted among systematically selected 349 TB/HIV co-infected patients who registered from 2012 to 2017 in two public hospitals in Harar town. The data were collected through document review by using a pre-tested structured data extraction checklist. The data were analyzed using SPSS Version 21. Bivariate and multivariate logistic regression were determined at 95% confidence intervals. Results Among the 349 TB/HIV co-infected patients included in the study, 30.1% were cured, 56.7% had completed their treatment, 7.7% died, 1.7% were lost to follow up, and 3.7% were treatment failure. Overall, 86.8% of the TB-HIV co-infected patients had successful TB treatment outcomes. The patients who were on re-treatment category (AOR = 2.91, 95% CI: 1.17–7.28), who had a history of opportunistic infection (AOR = 3.68, 95% CI: 1.62–8.33), and who did not take co-trimoxazole prophylaxis (AOR = 3.54, 95% CI: 1.59–7.89) had 2.91, 3.68, and 3.54 times higher odds of having unsuccessful TB treatment outcome than their counterparties, respectively. The chance of unsuccessful TB treatment outcome was 4.46 (95% CI: 1.24–16.02), 5.94 (95% CI: 1.87–18.85), and 3.01 (95% CI: 1.15–7.91) times higher among TB/HIV patients in stage 2, 3 and 4 than those in stage 1, respectively. Conclusions The overall rate of the success of the TB treatment among TB-HIV co-infected patients in this study was higher compared with many previous studies. TB/HIV patients with a history of previous TB treatment, smear-positive pulmonary TB, late HIV stage, history of opportunistic infection and not being on co-trimoxazole prophylaxis therapy were at a high risk of getting poor treatment outcomes.https://doi.org/10.1186/s12889-019-7980-xTB- HIV co-infectedTB treatment outcomeHarar
spellingShingle Assefa Tola
Kirubel Minsamo Mishore
Yohanes Ayele
Abraham Nigussie Mekuria
Nanati Legese
Treatment Outcome of Tuberculosis and Associated Factors among TB-HIV Co-Infected Patients at Public Hospitals of Harar Town, Eastern Ethiopia. A five-year retrospective study
BMC Public Health
TB- HIV co-infected
TB treatment outcome
Harar
title Treatment Outcome of Tuberculosis and Associated Factors among TB-HIV Co-Infected Patients at Public Hospitals of Harar Town, Eastern Ethiopia. A five-year retrospective study
title_full Treatment Outcome of Tuberculosis and Associated Factors among TB-HIV Co-Infected Patients at Public Hospitals of Harar Town, Eastern Ethiopia. A five-year retrospective study
title_fullStr Treatment Outcome of Tuberculosis and Associated Factors among TB-HIV Co-Infected Patients at Public Hospitals of Harar Town, Eastern Ethiopia. A five-year retrospective study
title_full_unstemmed Treatment Outcome of Tuberculosis and Associated Factors among TB-HIV Co-Infected Patients at Public Hospitals of Harar Town, Eastern Ethiopia. A five-year retrospective study
title_short Treatment Outcome of Tuberculosis and Associated Factors among TB-HIV Co-Infected Patients at Public Hospitals of Harar Town, Eastern Ethiopia. A five-year retrospective study
title_sort treatment outcome of tuberculosis and associated factors among tb hiv co infected patients at public hospitals of harar town eastern ethiopia a five year retrospective study
topic TB- HIV co-infected
TB treatment outcome
Harar
url https://doi.org/10.1186/s12889-019-7980-x
work_keys_str_mv AT assefatola treatmentoutcomeoftuberculosisandassociatedfactorsamongtbhivcoinfectedpatientsatpublichospitalsofharartowneasternethiopiaafiveyearretrospectivestudy
AT kirubelminsamomishore treatmentoutcomeoftuberculosisandassociatedfactorsamongtbhivcoinfectedpatientsatpublichospitalsofharartowneasternethiopiaafiveyearretrospectivestudy
AT yohanesayele treatmentoutcomeoftuberculosisandassociatedfactorsamongtbhivcoinfectedpatientsatpublichospitalsofharartowneasternethiopiaafiveyearretrospectivestudy
AT abrahamnigussiemekuria treatmentoutcomeoftuberculosisandassociatedfactorsamongtbhivcoinfectedpatientsatpublichospitalsofharartowneasternethiopiaafiveyearretrospectivestudy
AT nanatilegese treatmentoutcomeoftuberculosisandassociatedfactorsamongtbhivcoinfectedpatientsatpublichospitalsofharartowneasternethiopiaafiveyearretrospectivestudy